Recent research trends and updates on nonalcoholic fatty liver disease
Jeong-Ju Yoo, Won Kim, Moon Young Kim, Dae Won Jun, Sang Gyune Kim, Jong-Eun Yeon, Jin Woo Lee, Yong Kyun Cho, Sang Hoon Park, Joo Hyun Sohn,
Clin Mol Hepatol. 2019;25(1):1-11.   Published online 2018 Aug 8     DOI: https://doi.org/10.3350/cmh.2018.0037
Citations to this article as recorded by Crossref logo
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
Stergios A. Polyzos, Jannis Kountouras, Christos S. Mantzoros
Metabolism.2019; 92: 82.     CrossRef
Advancing the understanding of NAFLD to hepatocellular carcinoma development: From experimental models to humans
Kan Chen, Jianbo Ma, Xiaoyuan Jia, Wen Ai, Zhongren Ma, Qiuwei Pan
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.2019; 1871(1): 117.     CrossRef
Editorial: effect of hepatic steatosis on liver stiffness in patients with chronic hepatitis B
Beom Kyung Kim, Seung Up Kim
Alimentary Pharmacology & Therapeutics.2019; 50(3): 333.     CrossRef
Lack of association between early menopause and non-alcoholic fatty liver disease in postmenopausal women
S. H. Park, Y. E. Park, J. Lee, J. H. Choi, N. Y. Heo, J. Park, T. O. Kim, Y. S. Moon, H. K. Kim, H. J. Jang, H. Y. Park, C.-H. Jeong, K. T. Suk, D. J. Kim
Climacteric.2019; : 1.     CrossRef
Changes in real-life practice for hepatocellular carcinoma patients in the Republic of Korea over a 12-year period: A nationwide random sample study
Beom Kyung Kim, Do Young Kim, Kwang-Hyub Han, Jinsil Seong, Jung Weon Lee
PLOS ONE.2019; 14(10): e0223678.     CrossRef